Brazil lifts ban on controversial sterilization implants

July 11, 2017

Brazil has lifted a ban on the sale of Essure female sterilization implants after receiving results from clinical trials on its risks, authorities said Tuesday.

Sale of the implants, which was suspended in February, was authorized after its maker Bayer presented documents detailing that had been sought by the Brazilian Health Regulatory Agency (Anvisa).

These included results of that lasted a year or longer as well as a report on measures taken by the maker after a warning by Canada's health agency.

The so-called "permanent birth control" method involves the implantation of a metal coil in each fallopian tube which leads to the build-up of that forms a barrier preventing sperm from reaching eggs.

Acquired by German pharmaceutical firm Bayer in 2013, its use is being scrutinized by a number of countries, including the United States and France since 2015 following a surge of complaints about side effects.

About one million units have been sold worldwide since 2001.

Anvisa said its earlier suspension was brought about by the company's failure to respond to concerns on the product's safety.

Side effects can include changes to the menstrual cycle, unwanted pregnancies, chronic pain, perforations of the uterus and , migration of the device to the abdominal or pelvic cavity and suspected allergic or .

A collective lawsuit against Bayer is set to be filed in France in September by a group of 400 women, a lawyer representing them told AFP, while a Facebook group called "Essure Problems" currently counts more than 33,000 members.

Explore further: Women sue healthcare giant Bayer over contraceptive implants

Related Stories

Women sue healthcare giant Bayer over contraceptive implants

December 9, 2016
French lawyers for women who say a contraceptive implant sold by Bayer Healthcare had caused a string of medical complications launched a lawsuit against the multinational on Friday.

FDA reviewing safety of Essure birth control implant

June 25, 2015
Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

FDA explains pros, cons of permanent birth control

November 18, 2016
(HealthDay)—Women need to carefully consider the benefits and risks of permanent birth control devices, the U.S. Food and Drug Administration says.

FDA experts to review safety of Essure birth control implant

September 21, 2015
Federal medical experts will take a closer look at a host of problems reported with the birth control implant called Essure, including chronic pain, bleeding, headaches and allergic reactions.

FDA aims to publish Essure safety review in February

November 24, 2015
Federal health officials aim to release their findings on a much-debated contraceptive implant by the end of February.

FDA petitioned to stop sales of essure implant

May 5, 2015
(HealthDay)—Bayer's contraceptive implant Essure can cause serious complications and should be taken off the market, says a citizen's petition filed with the U.S. Food and Drug Administration.

Recommended for you

Hope for couples suffering IVF miscarriage

September 20, 2017
Women who miscarry during their first full round of IVF are more likely to have a baby after further treatment than women who don't get pregnant at all.

Does mother's mental health affect pregnancy?

September 13, 2017
(HealthDay)—Three common mental health disorders—depression, panic disorder and generalized anxiety disorder—pose no serious threat to pregnant women or the health of their babies, a new study finds.

Preeclampsia may boost heart disease risk by altering blood vessels

September 12, 2017
Preeclampsia may permanently change the blood vessels of women who experience the condition during pregnancy, boosting their lifelong risk for cardiovascular disease, according to Penn State researchers.

Discovery of genes linked to preterm birth in landmark study

September 6, 2017
A massive DNA analysis of pregnant women has identified six gene regions that influence the length of pregnancy and the timing of birth. The findings, published today in the New England Journal of Medicine, may lead to new ...

Older wombs linked to complications in pregnant mice

September 5, 2017
Deciding to start a family later in life could be about more than just the age of your eggs. A new study in mice suggests the age of a mother's womb may also have a part to play. This work, led by Dr Myriam Hemberger at the ...

Study suggests simple way to predict preterm births

September 4, 2017
Up to 18 percent of babies born worldwide arrive before they are full-term, defined as 37 weeks of gestation. About 1 million of those babies do not survive, and those who do can face developmental problems such as impaired ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.